份子疗法-核酸 SCIE

期刊简介估计审稿时候： 20 Weeks

Molecular Therapy — Nucleic Acids publishes research targeted to the advances in nucleic acid-based therapeutics to treat and/or correct genetic and acquired disease. Subject areas include: development of therapeutics based on nucleic acids and their derivatives, vector development and design for the delivery of RNA-based therapeutics, and applications of gene-modifying agents.

《份子疗法 — 核酸》颁发针对核酸疗法医治和/或改正遗传和后天疾病停顿的研讨。主题范畴包含：基于核酸及其衍生物的疗法的开辟、用于递送 RNA 疗法的载体开辟和设想和基因润色剂的利用。

《Molecular Therapy-nucleic Acids》(份子疗法-核酸)编辑部通信体例为50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, USA, MA, 02139。若是您须要辅佐投稿或润稿办事，您可以或许征询咱们的客服教员。咱们专一于期刊征询办事十年，熟习颁发政策，可为您供给一对一投稿指点，防止您在投稿时频仍碰鼻，节流您的可贵时候，有用晋升颁发机率，确保SCI检索（检索不了全额退款）。咱们视诺言为生命，多方面确保文章宁静失密，在任何环境下都不会泄漏您的小我信息或稿件内容。